The present study demonstrated that inhibiting MMP-9 expression using the CRISPR-Cas9 genome editing technique is feasible and can successfully impair T24 bladder cancer cell migration and invasion capacities in vitro. This evidence concerns the gene MMP9 and urinary bladder cancer.